Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Glucagon-Like Peptide-1 Infusion Improves Left Ventricular Ejection Fraction and Functional Status in Patients With Chronic Heart Failure
Recent scientific research indicates that molybdenum, a trace mineral that activates the enzymes aldehyde oxidase and sulfite oxidase, may provide necessary nutritional support for chemically sensitive individuals
No Observed Effects On: Blood glucose or insulin sensitivity (no diabetogenic effects) IGF-1 levels (remained within normal ranges) Blood pressure or cardiovascular parameters Thyroid function Liver or kidney function markers Important: The absence of growth hormone-related side effects distinguishes AOD-9604 from full-length GH, which can cause fluid retention, joint pain, carpal tunnel syndrome, and insulin resistance
It also acts as an anti-inflammatory in some of the animals on which it has been tested
A study published last summer by JAMA Oncology looked at GLP-1 use and 14 obesity-related cancers and found that while the weight-loss drug lowered the risk of most cancers, there was a nonsignificant increased risk of kidney cancer particularly among people younger than 65
